AT2R −1332 G:A polymorphism and its interaction with AT1R 1166 A:C, ACE I/D and MMP-9 −1562 C:T polymorphisms: Risk factors for susceptibility to preeclampsia

Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation

W. Anné, Rik Willems, Tania Roskams et al. · Cardiovascular Research · 2005 · 209 citations

Medicine, Cardiology, Clinical Cardiology +14

Comparative assessment of matrix metalloproteinase (MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension

Ana C. Palei, Valéria C. Sandrim, Ricardo de Carvalho Cavalli et al. · Clinical Biochemistry · 2008 · 107 citations

Medicine, Maternal Health, Obstetrics +15

Implications of the angiotensin converting enzyme gene insertion/deletion polymorphism in health and disease: a snapshot review.

Paul R. Gard · PubMed · 2010 · 81 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

Angiotensin II induces matrix metalloproteinase-9 expression via a nuclear factor-kappaB-dependent pathway in vascular smooth muscle cells

Ruiwei Guo, Lixia Yang, Hong Wang et al. · Regulatory Peptides · 2008 · 73 citations

Life Sciences, Molecular Biology, Physiology +14

Interaction between the polymorphisms of the renin–angiotensin system in preeclampsia

Ioanna Bouba, George Makrydimas, Rigas Kalaitzidis et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 2003 · 72 citations

Life Sciences, Genetics, Obstetrics +12